A Pestronk

The effect of thalidomide on experimental autoimmune myasthenia gravis.

A. Pestronk, K. Mcintosh, D. Drachman, 1989, Journal of autoimmunity.

Sensory exam with a quantitative tuning fork

A. Pestronk, J. Florence, M. Stambuk, 2004, Neurology.

Inflammatory myopathy with cytochrome oxidase negative muscle fibers: Methotrexate treatment

A. Pestronk, T. Levine, A Pestronk, 1998, Muscle & nerve.

Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.

Mark A. Levenstien, S. Leal, A. Pestronk, 2001, Molecular genetics and metabolism.

TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia

A. Pestronk, P. Hanson, M. Forman, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients

S. Dimauro, A. Pestronk, R. Griggs, 1996, Annals of neurology.

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy

A. Pestronk, A. Cnaan, A. Kornberg, 2011, Neurology.